Medizinische Universität Graz - Research portal
Selected Publication:
SHR
Neuro
Cancer
Cardio
Lipid
Metab
Microb
Cantalupo, A; Sasset, L; Gargiulo, A; Rubinelli, L; Del Gaudio, I; Benvenuto, D; Wadsack, C; Jiang, XC; Bucci, MR; Di Lorenzo, A.
Endothelial Sphingolipid De Novo Synthesis Controls Blood Pressure by Regulating Signal Transduction and NO via Ceramide.
Hypertension. 2020; 75(5):1279-1288
Doi: 10.1161/HYPERTENSIONAHA.119.14507
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
-
Del Gaudio Ilaria
-
Wadsack Christian
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
-
Ceramides are sphingolipids that modulate a variety of cellular processes via 2 major mechanisms: functioning as second messengers and regulating membrane biophysical properties, particularly lipid rafts, important signaling platforms. Altered sphingolipid levels have been implicated in many cardiovascular diseases, including hypertension, atherosclerosis, and diabetes mellitus-related conditions; however, molecular mechanisms by which ceramides impact endothelial functions remain poorly understood. In this regard, we generated mice defective of endothelial sphingolipid de novo biosynthesis by deleting the Sptlc2 (long chain subunit 2 of serine palmitoyltransferase)-the first enzyme of the pathway. Our study demonstrated that endothelial sphingolipid de novo production is necessary to regulate (1) signal transduction in response to NO agonists and, mainly via ceramides, (2) resting eNOS (endothelial NO synthase) phosphorylation, and (3) blood pressure homeostasis. Specifically, our findings suggest a prevailing role of C16:0-Cer in preserving vasodilation induced by tyrosine kinase and GPCRs (G-protein coupled receptors), except for Gq-coupled receptors, while C24:0- and C24:1-Cer control flow-induced vasodilation. Replenishing C16:0-Cer in vitro and in vivo reinstates endothelial cell signaling and vascular tone regulation. This study reveals an important role of locally produced ceramides, particularly C16:0-, C24:0-, and C24:1-Cer in vascular and blood pressure homeostasis, and establishes the endothelium as a key source of plasma ceramides. Clinically, specific plasma ceramides ratios are independent predictors of major cardiovascular events. Our data also suggest that plasma ceramides might be indicative of the diseased state of the endothelium.
- Find related publications in this database (using NLM MeSH Indexing)
-
Acetylcholine - pharmacology
-
Animals -
-
Blood Pressure - physiology
-
Cell Adhesion Molecules - metabolism
-
Cells, Cultured -
-
Ceramides - physiology
-
Endothelial Cells - metabolism
-
Histamine - pharmacology
-
Homeostasis -
-
Male -
-
Mice -
-
Mice, Transgenic -
-
Microfilament Proteins - metabolism
-
Nitric Oxide - agonists
-
Nitric Oxide - physiology
-
Nitric Oxide Synthase Type III - metabolism
-
Nitroprusside - pharmacology
-
Phosphoproteins - metabolism
-
Serine C-Palmitoyltransferase - deficiency
-
Signal Transduction -
-
Sphingolipids - biosynthesis
-
Vascular Endothelial Growth Factor Receptor-2 - physiology
-
Vasoconstriction - drug effects
-
Vasoconstriction - physiology
-
Vasodilation - drug effects
-
Vasodilation - physiology
- Find related publications in this database (Keywords)
-
blood pressure
-
ceramides
-
endothelial
-
sphingolipids
-
vascular resistance